tiprankstipranks
Trending News
More News >
Immunic (IMUX)
NASDAQ:IMUX
US Market

Immunic (IMUX) Income Statement

Compare
1,553 Followers

Immunic Income Statement

Last quarter (Q1 2025), Immunic's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q1, Immunic's net income was $-25.47M. See Immunic’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ -111.00K$ -77.00K$ -85.00K$ -39.00K
Operating Expenses
$ 98.05M$ 99.22M$ 86.52M$ 91.67M$ 48.97M
Depreciation and Amortization
$ 0.00$ 111.00K$ 77.00K$ 85.00K$ 39.00K
EBITDA
$ -100.37M$ -99.11M$ -120.33M$ -92.86M$ -48.93M
Operating Income
$ -98.05M$ -99.22M$ -119.49M$ -91.67M$ -48.97M
Other Income/Expenses
$ -2.46M$ 5.61M$ -919.00K$ -1.28M$ 4.95M
Pretax Income
$ -100.51M$ -93.61M$ -120.41M$ -92.94M$ -44.02M
Net Income
$ -100.51M$ -93.61M$ -154.30M$ -92.79M$ -43.96M
Per Share Metrics
Basic EPS
$ -1.00$ -2.11$ -4.85$ -3.92$ -2.81
Diluted EPS
$ -1.00$ -2.11$ -4.85$ -3.92$ -2.81
Weighted Average Shares Outstanding
100.17M 44.32M 31.82M 23.65M 15.66M
Weighted Average Shares Outstanding (Diluted)
100.17M 44.32M 31.82M 23.65M 15.66M
Currency in USD

Immunic Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis